The Main Directions of Clinical Application of Modern Proton Therapy

Author(s):  
А. Самойлов ◽  
A. Samoylov ◽  
Ж. Смирнова ◽  
Zh. Smirnova ◽  
В. Климанов ◽  
...  

This paper analyzes the current state of clinical application of proton radiation therapy (PRT) for the treatment of cancer. In particular, the indications for the use of PRT for the treatment of specific pathologies, the results and condition of randomized clinical studies of PRT compared to photon radiation therapy (PhRT) are considered, the cost of PRT is compared with the cost of PhRT. The focus is on discussing the results of PRT using in advanced countriesand Russia for the treatment of several common tumor sites. In the conclusion of the work, the ways of further improvement of radiobiology, dose delivering technology and dosimetric support of PRT are considered.

2018 ◽  
Vol 28 (2) ◽  
pp. 150-159 ◽  
Author(s):  
Jacobus Maarten Schippers ◽  
Anthony Lomax ◽  
Adriano Garonna ◽  
Katia Parodi

Author(s):  
Lyudmila Viktorovna Sotnikova

The article deals with the features of reflection in the accounting of organizations that are manufacturers of expensive medical equipment, the transfer of this medical equipment to non-operational (financial) lease to medical organizations. The article reviews the possibilities of proton therapy, manufacturers of equipment for proton therapy, including Russian ones. It is Russian manufacturers who are actively working on the development of compact proton accelerator samples that can be placed in any, not only specialized medical organizations. The article presents an example of accounting for accounting objects (revenue, cost, financial result (profit/loss)) arising on the date of conclusion of the contract of non-operational (financial) lease of equipment for proton radiation therapy.


Cancers ◽  
2015 ◽  
Vol 7 (2) ◽  
pp. 688-705 ◽  
Author(s):  
Wayne Newhauser ◽  
Rui Zhang ◽  
Timothy Jones ◽  
Annelise Giebeler ◽  
Phillip Taddei ◽  
...  

2020 ◽  
Vol 93 (1107) ◽  
pp. 20190359 ◽  
Author(s):  
Andries N. Schreuder ◽  
Jacob Shamblin

Proton radiation therapy has been used clinically since 1952, and major advancements in the last 10 years have helped establish protons as a major clinical modality in the cancer-fighting arsenal. Technologies will always evolve, but enough major breakthroughs have been accomplished over the past 10 years to allow for a major revolution in proton therapy. This paper summarizes the major technology advancements with respect to beam delivery that are now ready for mass implementation in the proton therapy space and encourages vendors to bring these to market to benefit the cancer population worldwide. We state why these technologies are essential and ready for implementation, and we discuss how future systems should be designed to accommodate their required features.


PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0248300
Author(s):  
Mehrdad Shahmohammadi Beni ◽  
Dragana Krstic ◽  
Dragoslav Nikezic ◽  
Kwan Ngok Yu

The Monte Carlo method was employed to simulate realistic treatment situations for photon and proton radiation therapy for a set of Oak Ridge National Laboratory (ORNL) pediatric phantoms for 15, 10, 5 and 1-year olds as well as newborns. Complete radiotherapy situations were simulated using the previously developed NRUrad input code for Monte Carlo N-Particle (MCNP) code package. Each pediatric phantom was irradiated at five different positions, namely, the testes, colon, liver, left lung and brain, and the doses in targeted organs (Dt) were determined using the track length estimate of energy. The dispersed photon and proton doses in non-targeted organs (Dd), namely, the skeleton, skin, brain, spine, left and right lungs were computed. The conversion coefficients (F = Dd/Dt) of the dispersed doses were used to study the dose dispersion in different non-targeted organs for phantoms for 15, 10, 5 and 1-year olds as well as newborns. In general, the F values were larger for younger patients. The F values for non-targeted organs for phantoms for 1-year olds and newborns were significantly larger compared to those for other phantoms. The dispersed doses from proton radiation therapy were also found to be significantly lower than those from conventional photon radiation therapy. For example, the largest F values for the brain were 65.6% and 0.206% of the dose delivered to the left lung (P4) for newborns during photon and proton radiation therapy, respectively. The present results demonstrated that dispersion of photons and generated electrons significantly affected the absorbed doses in non-targeted organs during pediatric photon therapy, and illustrated that proton therapy could in general bring benefits for treatment of pediatric cancer patients.


2020 ◽  
Vol 93 (1107) ◽  
pp. 20190845 ◽  
Author(s):  
Tonghe Wang ◽  
Jun Zhou ◽  
Sibo Tian ◽  
Yinan Wang ◽  
Pretesh Patel ◽  
...  

Objectives: The purpose of this study is to investigate the dosimetric effect and clinical impact of delivering a focal radiotherapy boost dose to multiparametric MRI (mp-MRI)-defined dominant intraprostatic lesions (DILs) in prostate cancer using proton therapy. Methods: We retrospectively investigated 36 patients with pre-treatment mp-MRI and CT images who were treated using pencil beam scanning (PBS) proton radiation therapy to the whole prostate. DILs were contoured on co-registered mp-MRIs. Simultaneous integrated boost (SIB) plans using intensity-modulated proton therapy (IMPT) were created based on conventional whole-prostate-irradiation for each patient and optimized with additional DIL coverage goals and urethral constraints. DIL dose coverage and organ-at-risk (OAR) sparing were compared between conventional and SIB plans. Tumor control probability (TCP) and normal tissue complication probability (NTCP) were estimated to evaluate the clinical impact of the SIB plans. Results: Optimized SIB plans significantly escalated the dose to DILs while meeting OAR constraints. SIB plans were able to achieve 125, 150 and 175% of prescription dose coverage in 74, 54 and 17% of 36 patients, respectively. This was modeled to result in an increase in DIL TCP by 7.3–13.3% depending on [Formula: see text] and DIL risk level. Conclusion: The proposed mp-MRI-guided DIL boost using proton radiation therapy is feasible without violating OAR constraints and demonstrates a potential clinical benefit by improving DIL TCP. This retrospective study suggested the use of IMPT-based DIL SIB may represent a strategy to improve tumor control. Advances in knowledge: This study investigated the planning of mp-MRI-guided DIL boost in prostate proton radiation therapy and estimated its clinical impact with respect to TCP and NTCP.


Author(s):  
В. Климанов ◽  
V. Klimanov ◽  
А. Самойлов ◽  
A. Samoylov ◽  
А. Гаджинов ◽  
...  

The most important stage of radiation therapy of oncological diseases is the planning of radiation treatment. In this work, this complex process in relation to proton therapy is proposed to be divided into medical and physical planning. In conventional therapy with photons and electrons, the latter is usually called dosimetric planning, however, when applied to proton radiation therapy, this stage involves a significantly wider range of tasks related to the modification and scanning of the proton beam, spreading and compensation of ranges, taking into account when planning for uncertainties and finiteness of proton ranges, a decrease in the contribution to the dose of secondary neutrons, the creation of error-tolerant optimization algorithms for dosimetric plans, and, finally, a precision calculation of dose distributions. The paper discusses the main stages and problems of physical planning of proton radiation therapy. Particular attention is paid to the formation of an extended high-dose region (extended Bragg peak) using the beam scattering method and scanning method, and to the algorithms for calculating the dose distributions created by protons in the scattering and beam scanning systems. The most detailed consideration is given to different versions of the proton pencil beam method, which allows to increase the dose calculation accuracy and take into account the transverse scattering and fluctuations in proton energy losses, especially at the end of the path (halo effect), analytical and numerical methods. Scanning are divided into three main technologies: homogeneous scanning, single field uniform dose (SFUD), multi-field uniform dose (MFUD), often called intensity modulated proton therapy (IMPT). Actual accounting problems are considered when planning the irradiation of the movement of organs, and uncertainties in determining path lengths and optimization of irradiation plans. In particular features, problems and modern approaches to the optimization of dosimetry plans of proton radiation therapy are discussed. It is noted that one of the most promising practical solutions for the uncertainty management in determining the path lengths of protons in optimization is to include possible errors in the objective function of the optimization algorithm. This technique ensures that an optimized irradiation plan will more reliably protect normal tissues and critical organs adjacent to the irradiation target from overexposure.


2018 ◽  
Vol 5 (1) ◽  
pp. 82-95 ◽  
Author(s):  
M. V. Zabelin ◽  
V. A. Klimanov ◽  
J. J. Galyautdinova ◽  
A. S. Samoilov ◽  
A. O. Lebedev ◽  
...  

2020 ◽  
Vol 9 (4) ◽  
pp. 5-17
Author(s):  
N.  V. Dengina ◽  
T. Mitin ◽  
N.  A. Vorobjov

The article presents two opinions regarding proton radiation therapy, its physical basis, dosimetric specifics and clinical efficacy in comparison with more traditional photon irradiation, as well as the authors» opinions concerning the expanding indications for proton therapy and the rationale for opening new centers for proton treatment in the world. This review has become a continuation of the discussion session on proton therapy held at the XXIII Russian Oncology Congress in November 2019.


Sign in / Sign up

Export Citation Format

Share Document